5 Most Profitable Drugs In The World

4. Paxlovid

2022 Sales: $18.93 billion 

Paxlovid by Pfizer,Inc. (NYSE:PFE) is an oral antiviral therapy developed to prevent severe COVID-19 and stands fourth among the most profitable drugs in the world. With impressive sales of $18.93 billion in 2022, it has shown promise in reducing hospitalization and death rates. Paxlovid offers an alternative treatment option to mitigate the severe outcomes of the disease, contributing to the global fight against COVID-19.